WASHINGTON — Republicans in Congress are working to relax a law that would force drug makers to pay a higher percentage of costs for Medicare beneficiaries.

Democratic aides, including in House leadership, and a spate of health industry lobbyists confirmed that House Republicans are trying to use an upcoming spending bill to make the change at the behest of the pharmaceutical industry, which has spent the weeks since the law was enacted in February blasting the policy. Whether the industry can agree to the particulars of a “fix” before a March 23 deadline and whether Democrats will accept the policy is still up in the air.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy